Kala Bio Inc has a consensus price target of $9.63, established from looking at the 18 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and Oppenheimer on May 17, 2024, April 2, 2024, and April 1, 2024. With an average price target of $18 between HC Wainwright & Co., HC Wainwright & Co., and Oppenheimer, there's an implied 165.10% upside for Kala Bio Inc from these 3 analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/17/2024 | Buy Now | 165.1% | HC Wainwright & Co. | Yi Chen | $21 → $18 | Maintains | Buy | Get Alert |
04/02/2024 | Buy Now | 209.28% | HC Wainwright & Co. | Yi Chen | $22 → $21 | Maintains | Buy | Get Alert |
04/01/2024 | Buy Now | 120.91% | Oppenheimer | Francois Brisebois | $15 → $15 | Reiterates | Outperform → Outperform | Get Alert |
11/17/2023 | Buy Now | 224.01% | HC Wainwright & Co. | Yi Chen | $24 → $22 | Maintains | Buy | Get Alert |
08/11/2023 | Buy Now | 253.46% | HC Wainwright & Co. | Yi Chen | → $24 | Reiterates | Buy → Buy | Get Alert |
05/10/2023 | Buy Now | 253.46% | HC Wainwright & Co. | Yi Chen | $22 → $24 | Reiterates | → Buy | Get Alert |
05/01/2023 | Buy Now | 224.01% | HC Wainwright & Co. | Yi Chen | → $22 | Reiterates | → Buy | Get Alert |
04/12/2023 | Buy Now | 224.01% | HC Wainwright & Co. | Yi Chen | $20 → $22 | Maintains | Buy | Get Alert |
03/27/2023 | Buy Now | 194.55% | HC Wainwright & Co. | Yi Chen | → $20 | Reiterates | → Buy | Get Alert |
03/06/2023 | Buy Now | 194.55% | HC Wainwright & Co. | Yi Chen | $12 → $20 | Maintains | Buy | Get Alert |
08/15/2022 | Buy Now | -63.18% | HC Wainwright & Co. | Yi Chen | $200 → $125 | Maintains | Buy | Get Alert |
05/24/2022 | Buy Now | -41.09% | HC Wainwright & Co. | Yi Chen | $250 → $200 | Maintains | Buy | Get Alert |
05/17/2022 | Buy Now | -26.36% | HC Wainwright & Co. | Yi Chen | $300 → $250 | Maintains | Buy | Get Alert |
03/30/2022 | Buy Now | -41.09% | Northland Capital Markets | Tim Chiang | $300 → $200 | Maintains | Outperform | Get Alert |
03/30/2022 | Buy Now | -11.63% | HC Wainwright & Co. | Yi Chen | $450 → $300 | Maintains | Buy | Get Alert |
03/30/2022 | Buy Now | -77.91% | JP Morgan | Christopher Neyor | → $75 | Downgrade | Neutral → Underweight | Get Alert |
08/06/2021 | Buy Now | 62% | HC Wainwright & Co. | Yi Chen | — | Maintains | Buy | Get Alert |
08/06/2021 | Buy Now | — | JP Morgan | Christopher Neyor | — | Downgrade | Overweight → Neutral | Get Alert |
The latest price target for Kala Bio (NASDAQ:KALA) was reported by HC Wainwright & Co. on May 17, 2024. The analyst firm set a price target for $18.00 expecting KALA to rise to within 12 months (a possible 165.10% upside). 5 analyst firms have reported ratings in the last year.
The latest analyst rating for Kala Bio (NASDAQ:KALA) was provided by HC Wainwright & Co., and Kala Bio maintained their buy rating.
There is no last upgrade for Kala Bio
The last downgrade for Kala Bio Inc happened on March 30, 2022 when JP Morgan changed their price target from N/A to $1.5 for Kala Bio Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Kala Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Kala Bio was filed on May 17, 2024 so you should expect the next rating to be made available sometime around May 17, 2025.
While ratings are subjective and will change, the latest Kala Bio (KALA) rating was a maintained with a price target of $21.00 to $18.00. The current price Kala Bio (KALA) is trading at is $6.79, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.